BD CTGCTV2 for BD COR™ System

Description

FDA - Cleared assays that combines the 3 most prevalent non-viral STIs in one test for asymptomatic and symptomatic individuals

• 3-in-1 assay for the 3 most common non-viral STIs
  • Chlamydia trachomatis (CT)
  • Neisseria gonorrhoeae (GC)
  • Trichomonas vaginalis (TV)
• Approved for Symptomatic and Assymptomatic testing
• Sample types include:
  • Urine - CT, GC, TV
  • Liquid-Based Cytology (LBC) specimens - CT, GC
  • Endocervical Swab - CT, GC
  • Vaginal Swab - Self Collected - CT, GC, TV
  • Vaginal Swab - Clinician Collected - CT, GC, TV
  • Rectal Swab - Clinician Collected - CT, GC
  • Oropharyngeal Swab - Clinician Collected - CT, GC
• Includes Trichomonas vaginalis infections that tend to be asymptomatic
• Includes dual gene targets for GC, which maximizes the assay specificity: both GC gene targets are required for a positive GC result
• Compatible with the BD Vaginal Panel for BD COR™ System for comprehensive testing of vaginitis and STIs

Specifications

• Content And Storage: 2°C to 27°C
• Type: Assay Kit
• Includes: Master Mix, Liquid Extraction Reagent Plate
• Quantity: 1 Pk.
• Dimensions (L x W x H): 32 x 29 x 33 mm
• Weight (English): 5 lb.
• Electrical Requirements: None
• Form: Ready-to-Use (RTU)
• Operating Temperature Range: Up to 32°C